BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma-Reference-Cited by-同舟云学术

BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma

Published:2024-05-21 Issue:13 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Watanabe Jun,Clutter Matthew R.,Gullette Michael J.,Sasaki Takahiro,Uchida Eita,Kaur Savneet,Mo Yan,Abe Kouki,Ishi Yukitomo^ORCID,Takata Nozomu^ORCID,Natsumeda Manabu,Gadd Samantha,Zhang Zhiguo,Becher Oren J.,Hashizume Rintaro^ORCID

Funder

National Institutes of Health

Rally Foundation

Pediatric Cancer Research Foundation

Cure Starts Now Foundation

Matthew Larson Foundation for Pediatric Brain Tumors

Japan Society for the Promotion of Science

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/174794/files/pdf

Reference66 articles.

1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2. Diffuse intrinsic pontine glioma: a reassessment

3. The Integration of Biology Into the Treatment of Diffuse Intrinsic Pontine Glioma: A Review of the North American Clinical Trial Perspective

4. Interdisciplinary care of children with diffuse midline glioma

5. Radiotherapy for Diffuse Intrinsic Pontine Glioma: Insufficient but Indispensable

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition;2024-08-27

2. Chromatin remodeling with combined FACT and BET inhibition disrupts oncogenic transcription in Diffuse Midline Glioma;2024-06-09